CRGX
COM:CARGO-TX
CARGO Therapeutics
- Stock
Last Close
15.73
22/11 21:00
Market Cap
761.31M
Beta: -
Volume Today
156.59K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -12.29M - | -13.75M 11.92% | -12.75M 7.29% | -17.85M 40.05% | -35.47M 98.69% | -32.08M 9.57% | -35.81M 11.64% | -44.35M 23.84% | -41.91M 5.50% | |
depreciation and amortization | 362K - | 430K 18.78% | 683K 58.84% | 859K 25.77% | 1.05M 22.12% | 1.10M 4.96% | 1.85M 68.39% | 2.06M 11.17% | 1.80M 12.86% | |
deferred income tax | 30K - | |||||||||
stock based compensation | 24K - | 32K 33.33% | 31K 3.13% | 592K 1,809.68% | 1.08M 83.11% | 1.62M 49.45% | 3.90M 140.99% | 4.93M - | ||
change in working capital | 1.03M - | -810K 178.49% | -20K 97.53% | 864K 4,420% | 1.71M 98.03% | -346K 120.22% | 2.09M 702.89% | 4.20M 101.15% | -6.28M 249.71% | |
accounts receivables | ||||||||||
inventory | ||||||||||
accounts payables | 2.90M - | -2.96M 202.35% | -2.70M 8.88% | 4.08M 251.26% | 1.91M 53.16% | -2.54M 232.78% | 2.67M 205.28% | -351K 113.13% | -1.27M 261.82% | |
other working capital | -1.86M - | 2.15M 215.57% | -202K - | 2.19M 1,186.14% | 4.55M - | -5.01M 210.23% | ||||
other non cash items | 2.39M - | 2.72M 13.63% | 2.13M 21.72% | 635K 70.15% | 8.41M 1,224.41% | 720K 91.44% | 150K 79.17% | 7.48M 4,886.67% | 1.84M 75.43% | |
net cash provided by operating activities | -8.48M - | -11.35M 33.91% | -14.06M 23.90% | -14.90M 5.97% | -23.22M 55.80% | -28.98M 24.83% | -30.15M 4.02% | -35.08M 16.38% | -39.63M 12.94% | |
investments in property plant and equipment | -553K - | -1.02M 85.17% | -619K 39.55% | -1.49M 141.36% | -3.90M 161.38% | -2.97M 23.84% | -1.62M 45.56% | -1.46M 9.64% | -735K 49.76% | |
acquisitions net | ||||||||||
purchases of investments | -292.34M - | -68.05M 76.72% | -133.31M 95.92% | |||||||
sales maturities of investments | 73.80M - | 86.86M 17.70% | ||||||||
other investing activites | -263K - | -500K - | 4.01M 901.20% | |||||||
net cash used for investing activites | -816K - | -1.02M 25.49% | -619K 39.55% | -1.49M 141.36% | -3.90M 161.38% | -2.97M 23.84% | -293.96M 9,784.20% | 3.79M 101.29% | -43.18M 1,239.09% | |
debt repayment | 3.97M - | -3.50M - | ||||||||
common stock issued | 103.22M - | -357K 100.35% | ||||||||
common stock repurchased | ||||||||||
dividends paid | ||||||||||
other financing activites | 3K - | 377.91M - | -130K 100.03% | 130K 200% | 402K 209.23% | |||||
net cash used provided by financing activities | 3.98M - | 12.72M 220.00% | 71.58M 462.70% | 2K 100.00% | 45.09M 2,254,650% | 377.91M 738.03% | -104K 100.03% | 103.35M 99,474.04% | 402K 99.61% | |
effect of forex changes on cash | ||||||||||
net change in cash | -5.32M - | 346K 106.51% | 56.89M 16,343.06% | -16.39M 128.82% | 17.97M 209.63% | 345.95M 1,824.86% | -324.21M 193.71% | 72.06M 122.23% | -81.84M 213.58% | |
cash at beginning of period | 6.84M - | 1.53M 77.70% | 1.87M 22.67% | 58.77M 3,039.16% | 42.37M 27.90% | 60.34M 42.42% | 406.30M 573.30% | 81.53M 79.93% | 153.58M 88.38% | |
cash at end of period | 1.53M - | 1.87M 22.67% | 58.77M 3,039.16% | 42.37M 27.90% | 60.34M 42.42% | 406.30M 573.30% | 82.09M 79.79% | 153.58M 87.08% | 71.74M 53.29% | |
operating cash flow | -8.48M - | -11.35M 33.91% | -14.06M 23.90% | -14.90M 5.97% | -23.22M 55.80% | -28.98M 24.83% | -30.15M 4.02% | -35.08M 16.38% | -39.63M 12.94% | |
capital expenditure | -816K - | -1.02M 25.49% | -619K 39.55% | -1.49M 141.36% | -3.90M 161.38% | -2.97M 23.84% | -1.62M 45.56% | -1.46M 9.64% | -735K 49.76% | |
free cash flow | -9.29M - | -12.37M 33.17% | -14.68M 18.65% | -16.40M 11.67% | -27.12M 65.42% | -31.96M 17.82% | -31.77M 0.60% | -36.55M 15.05% | -40.36M 10.43% |
All numbers in USD (except ratios and percentages)